Global Nucleic Acid Amplification Testing Market Growth (Status and Outlook) 2021-2026

Global Nucleic Acid Amplification Testing Market Growth (Status and Outlook) 2021-2026

According to this latest study, the 2020 growth of Nucleic Acid Amplification Testing will have significant change from previous year. By the most conservative estimates of global Nucleic Acid Amplification Testing market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ 128.7 million in 2019. Over the next five years the Nucleic Acid Amplification Testing market will register a 4.5% CAGR in terms of revenue, the global market size will reach US$ 153.3 million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Nucleic Acid Amplification Testing market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2016 to 2021 in Section 2.3; and forecast to 2026 in section 10.7.
Target Amplification Systems
Probe Amplification Systems
Signal Amplification

Segmentation by application: breakdown data from 2016 to 2021, in Section 2.4; and forecast to 2026 in section 10.8.
Infectious Diseases
Cancer
Personalized Medicine
Genetic and Mitochondrial Disorders

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
F. Hoffmann-La Roche
Becton
Dickinson and Company
Beckman Coulter
Abbott Laboratories
Illumina
Siemens Healthineers
bioMerieux
Novartis
Bio-Rad Laboratories

Please note: The report will take approximately 2 business days to prepare and deliver.


1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nucleic Acid Amplification Testing Market Size 2016-2026
2.1.2 Nucleic Acid Amplification Testing Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Nucleic Acid Amplification Testing Segment by Type
2.2.1 Target Amplification Systems
2.2.2 Target Amplification Systems
2.2.3 Signal Amplification
2.3 Nucleic Acid Amplification Testing Market Size by Type
2.3.1 Global Nucleic Acid Amplification Testing Market Size CAGR by Type
2.3.2 Global Nucleic Acid Amplification Testing Market Size Market Share by Type (2016-2021)
2.4 Nucleic Acid Amplification Testing Segment by Application
2.4.1 Infectious Diseases
2.4.2 Cancer
2.4.3 Personalized Medicine
2.4.4 Genetic and Mitochondrial Disorders
2.5 Nucleic Acid Amplification Testing Market Size by Application
2.5.1 Global Nucleic Acid Amplification Testing Market Size CAGR by Application
2.5.2 Global Nucleic Acid Amplification Testing Market Size Market Share by Application (2016-2021)
3 Global Nucleic Acid Amplification Testing by Players
3.1 Nucleic Acid Amplification Testing Market Size Market Share by Players
3.1.1 Global Nucleic Acid Amplification Testing Revenue by Players (2019-2021E)
3.1.2 Global Nucleic Acid Amplification Testing Revenue Market Share by Players (2019-2021E)
3.2 Global Nucleic Acid Amplification Testing Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Nucleic Acid Amplification Testing by Regions
4.1 Nucleic Acid Amplification Testing Market Size by Regions (2016-2021)
4.2 Americas Nucleic Acid Amplification Testing Market Size Growth (2016-2021)
4.3 APAC Nucleic Acid Amplification Testing Market Size Growth (2016-2021)
4.4 Europe Nucleic Acid Amplification Testing Market Size Growth (2016-2021)
4.5 Middle East & Africa Nucleic Acid Amplification Testing Market Size Growth (2016-2021)
5 Americas
5.1 Americas Nucleic Acid Amplification Testing Market Size by Country (2016-2021)
5.2 Americas Nucleic Acid Amplification Testing Market Size by Type (2016-2021)
5.3 Americas Nucleic Acid Amplification Testing Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nucleic Acid Amplification Testing Market Size by Region (2016-2021)
6.2 APAC Nucleic Acid Amplification Testing Market Size by Type (2016-2021)
6.3 APAC Nucleic Acid Amplification Testing Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Nucleic Acid Amplification Testing by Country (2016-2021)
7.2 Europe Nucleic Acid Amplification Testing Market Size by Type (2016-2021)
7.3 Europe Nucleic Acid Amplification Testing Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nucleic Acid Amplification Testing by Region (2016-2021)
8.2 Middle East & Africa Nucleic Acid Amplification Testing Market Size by Type (2016-2021)
8.3 Middle East & Africa Nucleic Acid Amplification Testing Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Nucleic Acid Amplification Testing Market Forecast
10.1 Global Nucleic Acid Amplification Testing Forecast by Regions (2021-2026)
10.1.1 Global Nucleic Acid Amplification Testing Forecast by Regions (2021-2026)
10.1.2 Americas Nucleic Acid Amplification Testing Forecast
10.1.3 APAC Nucleic Acid Amplification Testing Forecast
10.1.4 Europe Nucleic Acid Amplification Testing Forecast
10.1.5 Middle East & Africa Nucleic Acid Amplification Testing Forecast
10.2 Americas Nucleic Acid Amplification Testing Forecast by Countries (2021-2026)
10.2.1 United States Nucleic Acid Amplification Testing Market Forecast
10.2.2 Canada Nucleic Acid Amplification Testing Market Forecast
10.2.3 Mexico Nucleic Acid Amplification Testing Market Forecast
10.2.4 Brazil Nucleic Acid Amplification Testing Market Forecast
10.3 APAC Nucleic Acid Amplification Testing Forecast by Region (2021-2026)
10.3.1 China Nucleic Acid Amplification Testing Market Forecast
10.3.2 Japan Nucleic Acid Amplification Testing Market Forecast
10.3.3 Korea Nucleic Acid Amplification Testing Market Forecast
10.3.4 Southeast Asia Nucleic Acid Amplification Testing Market Forecast
10.3.5 India Nucleic Acid Amplification Testing Market Forecast
10.3.6 Australia Nucleic Acid Amplification Testing Market Forecast
10.4 Europe Nucleic Acid Amplification Testing Forecast by Country (2021-2026)
10.4.1 Germany Nucleic Acid Amplification Testing Market Forecast
10.4.2 France Nucleic Acid Amplification Testing Market Forecast
10.4.3 UK Nucleic Acid Amplification Testing Market Forecast
10.4.4 Italy Nucleic Acid Amplification Testing Market Forecast
10.4.5 Russia Nucleic Acid Amplification Testing Market Forecast
10.5 Middle East & Africa Nucleic Acid Amplification Testing Forecast by Region (2021-2026)
10.5.1 Egypt Nucleic Acid Amplification Testing Market Forecast
10.5.2 South Africa Nucleic Acid Amplification Testing Market Forecast
10.5.3 Israel Nucleic Acid Amplification Testing Market Forecast
10.5.4 Turkey Nucleic Acid Amplification Testing Market Forecast
10.5.5 GCC Countries Nucleic Acid Amplification Testing Market Forecast
10.6 Global Nucleic Acid Amplification Testing Forecast by Type (2021-2026)
10.8 Global Nucleic Acid Amplification Testing Forecast by Application (2021-2026)
11 Key Players Analysis
11.1 F. Hoffmann-La Roche
11.1.1 F. Hoffmann-La Roche Company Information
11.1.2 F. Hoffmann-La Roche Nucleic Acid Amplification Testing Product Offered
11.1.3 F. Hoffmann-La Roche Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 F. Hoffmann-La Roche Main Business Overview
11.1.5 F. Hoffmann-La Roche Latest Developments
11.2 Becton
11.2.1 Becton Company Information
11.2.2 Becton Nucleic Acid Amplification Testing Product Offered
11.2.3 Becton Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Becton Main Business Overview
11.2.5 Becton Latest Developments
11.3 Dickinson and Company
11.3.1 Dickinson and Company Company Information
11.3.2 Dickinson and Company Nucleic Acid Amplification Testing Product Offered
11.3.3 Dickinson and Company Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Dickinson and Company Main Business Overview
11.3.5 Dickinson and Company Latest Developments
11.4 Beckman Coulter
11.4.1 Beckman Coulter Company Information
11.4.2 Beckman Coulter Nucleic Acid Amplification Testing Product Offered
11.4.3 Beckman Coulter Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Beckman Coulter Main Business Overview
11.4.5 Beckman Coulter Latest Developments
11.5 Abbott Laboratories
11.5.1 Abbott Laboratories Company Information
11.5.2 Abbott Laboratories Nucleic Acid Amplification Testing Product Offered
11.5.3 Abbott Laboratories Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Abbott Laboratories Main Business Overview
11.5.5 Abbott Laboratories Latest Developments
11.6 Illumina
11.6.1 Illumina Company Information
11.6.2 Illumina Nucleic Acid Amplification Testing Product Offered
11.6.3 Illumina Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Illumina Main Business Overview
11.6.5 Illumina Latest Developments
11.7 Siemens Healthineers
11.7.1 Siemens Healthineers Company Information
11.7.2 Siemens Healthineers Nucleic Acid Amplification Testing Product Offered
11.7.3 Siemens Healthineers Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 Siemens Healthineers Main Business Overview
11.7.5 Siemens Healthineers Latest Developments
11.8 bioMerieux
11.8.1 bioMerieux Company Information
11.8.2 bioMerieux Nucleic Acid Amplification Testing Product Offered
11.8.3 bioMerieux Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 bioMerieux Main Business Overview
11.8.5 bioMerieux Latest Developments
11.9 Novartis
11.9.1 Novartis Company Information
11.9.2 Novartis Nucleic Acid Amplification Testing Product Offered
11.9.3 Novartis Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Novartis Main Business Overview
11.9.5 Novartis Latest Developments
11.10 Bio-Rad Laboratories
11.10.1 Bio-Rad Laboratories Company Information
11.10.2 Bio-Rad Laboratories Nucleic Acid Amplification Testing Product Offered
11.10.3 Bio-Rad Laboratories Nucleic Acid Amplification Testing Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Bio-Rad Laboratories Main Business Overview
11.10.5 Bio-Rad Laboratories Latest Developments
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings